πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10711312

Methods for immunotherapy-based treatment and assessment of cancer

The Regents of the University of California Β· Granted Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10703797

Gene therapy vectors for treatment of Danon disease

Rocket Pharmaceuticals, Ltd. Β· Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10703701

Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone deri

PTC THERAPEUTICS, INC. Β· Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10703735

4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the tr

Lead Discovery Center GmbH Β· Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10702569

Compositions and methods for treatment of pain

Princeton Biotechnology Corporation Β· Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10695355

Methods for pharmacologic treatment of stroke

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10696718

Compstatin analogs for treatment of neuropathic pain

Apellis Pharmaceuticals, Inc. Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10689646

Treatment of genetic disorders associated with DNA repeat instability

BIOMARIN TECHNOLOGIES B.V. Β· Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10689443

Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colo

PRECISION BIOLOGICS, INC. Β· Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10688080

Compositions, methods of use, and methods of treatment

The Regents of the University of California Β· Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10688102

Combination treatment for migraine and other pain

AXSOME THERAPEUTICS, INC. Β· Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10688181

Cancer treatment combinations

The Regents of the University of California Β· Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10682339

Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10683347

Treatment of cancer using anti-TGF-Ξ² and anti-PD-1 antibodies

The Regents of the University of California Β· Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10683366

Methods and compositions for treatment of atherosclerosis

The Board of Regents of the University of Texas System Β· Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10683503

Antisense oligomers for treatment of conditions and diseases

STOKE THERAPEUTICS, INC. Β· Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10676533

Methods of treatment of CD123 overexpressing disorders

Aptevo Research and Development LLC Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10675258

Method of using gamma-hydroxybutyrate compositions for the treatment of disorders

Jazz Pharmaceuticals Ireland Limited Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10675271

Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adver

Monopar Therapeutics Inc. Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10675272

Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

PTC THERAPEUTICS, INC. Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10677801

Diagnosis and treatment of breast cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10675303

Extracellular matrix compositions for the treatment of cancer

Adaptive Biologix, Inc. Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10675304

Combination immunotherapies for treatment of cancer

PrimeVax Immuno-Oncology Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10676452

Compound for the prophylaxis or treatment of organ damage

Sulfateq B.V. Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted